Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00081302
Status:
COMPLETED
Last Update Posted:
2015-11-17
First Post:
2004-04-07
Brief Title:
Cetuximab Paclitaxel Carboplatin and Radiation Therapy in Treating Patients With Unresectable Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer
Sponsor:
Radiation Therapy Oncology Group
Organization:
Radiation Therapy Oncology Group
Organization Data
Organization:
Radiation Therapy Oncology Group
Class:
NETWORK
Study ID:
RTOG-0324
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Radiation Therapy Oncology Group
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |